NCT05922137

Brief Summary

To test the effects of 6 month additional intervention of ORIENT diet versus usual medical treatment for Intracranial / Carotid Stenosis on cognitive decline, multi-mode MRI image markers and serum and fecal biomarkers in a randomized controlled trial of 120 patients with intracranial / carotid stenosis, who are aged older than 40 years and without dementia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
13mo left

Started May 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
May 2023May 2027

Study Start

First participant enrolled

May 1, 2023

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

May 7, 2023

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 21, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 28, 2023

Completed
3.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Expected
Last Updated

June 15, 2025

Status Verified

September 1, 2024

Enrollment Period

20 days

First QC Date

May 7, 2023

Last Update Submit

June 11, 2025

Conditions

Keywords

Cognitive decline

Outcome Measures

Primary Outcomes (1)

  • Global cognitive function change assessed with Z-score of a modified National Institute of Neurological Disorders and Stroke and Canadian Stroke Network-Canadian Stroke Network (NINDS-CSN) protocol

    Primary Outcome

    6 months

Secondary Outcomes (13)

  • Cognitive domain change assessed with NINDS-CSN protocol, including working memory, executive function, language, visual motor speed, visual spatial function, memory and recognition

    6 months

  • Cognitive function change assessed by Montreal Cognitive Assessment (minimum value = 0, maximum value = 30, and higher scores mean a better outcome)

    6 months

  • Changes in functional network-related characteristics assessed by functional magnetic resonance imaging (fMRI), including intra- and inter-network connectivity, graph theory, and dynamic functional connectivity

    6 months

  • Changes in white matter hyperintensity (WMH) assessed on MRI with T2-Fluid-Attenuated-Inversion-Recovery (FLAIR) sequence

    6 months

  • Changes in cerebral glymphatic function assessed by non-invasive diffusion tensor image analysis along the perivascular space (ALPS-index)

    6 months

  • +8 more secondary outcomes

Study Arms (2)

Usual Diet advice

PLACEBO COMPARATOR

Usual diet advice + standard medical treatment

Behavioral: Usual Diet advice

ORIENT diet intervention

ACTIVE COMPARATOR

6 month intervention of ORIENT diet + standard medical treatment

Behavioral: Oriental Intervention for Enhanced Neurocognitive Health (ORIENT) diet

Interventions

The usual diet advice include recommendations in guidelines, such as reducing salt and limiting alcohol consumption

Usual Diet advice

The ORIENT diet has the same basic components of the Dietary Approaches to Stop Hypertension (DASH), Mediterranean and MIND diets, but uniquely adjusting some of components according to the evidence derived from Asian prospective cohorts and the Chinese eating habits.

ORIENT diet intervention

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged ≥ 40 years
  • ≥ 50% stenosis in unilateral intracranial / carotid artery
  • Written informed consent available
  • Willingness to complete all assessments and participate in follow-up
  • Adequate Visual and auditory acuity to undergo neuropsychological testing

You may not qualify if:

  • Previous history of major head trauma and any intracranial surgery
  • Intracranial abnormalities, such as intracerebral hemorrhage, subarachnoid hemorrhage and other space occupying lesions
  • Extrapyramidal symptoms or mental illness which may affect neuropsychological measurement
  • Severe loss of vision, hearing, or communicative ability
  • Nuts, berries, olive oil, or fish allergies
  • Patients presenting a malignant disease with life expectancy \< 3 years
  • Participation in an ongoing investigational drug study
  • Exit Criteria:
  • For any poor adherence, not comply with the requirements of the follow-up, or safety reasons determined by investigator
  • Any adverse or serious adverse events during the study period judged by Investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affilated Hospital of Zhejiang University, School of Medicine

Hangzhou, Zhejiang, 310009, China

RECRUITING

MeSH Terms

Conditions

Cognitive DysfunctionConstriction, PathologicDementia

Interventions

Diet

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Min Lou, PhD, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 7, 2023

First Posted

June 28, 2023

Study Start

May 1, 2023

Primary Completion

May 21, 2023

Study Completion (Estimated)

May 31, 2027

Last Updated

June 15, 2025

Record last verified: 2024-09

Locations